메뉴 건너뛰기




Volumn 27, Issue 8, 2009, Pages 443-444

Biogenerics: the hope and the hype

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ETANERCEPT; GENERIC DRUG; HUMAN GROWTH HORMONE; HYALURONIDASE; HYLENEX; LUMIZYME; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GLUCAGON; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; SALCATONIN; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

EID: 67650692717     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2009.04.005     Document Type: Note
Times cited : (6)

References (5)
  • 1
    • 67650659933 scopus 로고    scopus 로고
    • Anonymous (2009) Senators Announce Bipartisan Proposal To Bring Generic Biologic Drugs To Market, Saving Billions In Medicare Costs [Press release, 26 March 2009] (http://vitter.senate.gov/public/index.cfm?FuseAction=PressRoom.PressReleases&ContentRecord_id=482f3d72-a00d-ec7a-e599-a874f852c445&Region_id=&Issue_id=1440e2b6-2a4f-433e-b31a-58a675aa6790, accessed April 2, 2009)
    • Anonymous (2009) Senators Announce Bipartisan Proposal To Bring Generic Biologic Drugs To Market, Saving Billions In Medicare Costs [Press release, 26 March 2009] (http://vitter.senate.gov/public/index.cfm?FuseAction=PressRoom.PressReleases&ContentRecord_id=482f3d72-a00d-ec7a-e599-a874f852c445&Region_id=&Issue_id=1440e2b6-2a4f-433e-b31a-58a675aa6790, accessed April 2, 2009)
  • 2
    • 67650689225 scopus 로고    scopus 로고
    • Editorial (2008) Merck to Develop Biotech Generics, The Wall Street Journal 10 December, p. B1 (http://online.wsj.com/article/SB122883224274591361.html?mod=wsjcrmain, accessed April 2, 2009)
    • Editorial (2008) Merck to Develop Biotech Generics, The Wall Street Journal 10 December, p. B1 (http://online.wsj.com/article/SB122883224274591361.html?mod=wsjcrmain, accessed April 2, 2009)
  • 3
    • 4644351840 scopus 로고    scopus 로고
    • Pure red-cell aplasia and epoetin therapy
    • Bennett C.L., et al. Pure red-cell aplasia and epoetin therapy. N. Engl. J. Med. 351 (2004) 1403-1408
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1403-1408
    • Bennett, C.L.1
  • 4
    • 67650668649 scopus 로고    scopus 로고
    • Woodcock, J. (2007) Follow-on Protein Products: Statement of Janet Woodcock, M.D. Deputy Commissioner, Chief Medical Officer, Food and Drug Administration, before The Committee on Oversight and Government Reform United States House of Representatives, March 26, 2007 (http://www.fda.gov/NewsEvents/Testimony/ucm154070.htm, accessed June 15, 2009)
    • Woodcock, J. (2007) Follow-on Protein Products: Statement of Janet Woodcock, M.D. Deputy Commissioner, Chief Medical Officer, Food and Drug Administration, before The Committee on Oversight and Government Reform United States House of Representatives, March 26, 2007 (http://www.fda.gov/NewsEvents/Testimony/ucm154070.htm, accessed June 15, 2009)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.